跳至主要内容
临床试验/NL-OMON51077
NL-OMON51077已完成不适用

Gastric digestion and post-prandial absorption of infant formula differing in protein composition, particularly in whey and casein composition. - Gastric Layering and Monitoring (GLAM II)

Wageningen Universiteit0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Age 18 * 45 y
  • Healthy (self-reported)
  • Normal-weight (BMI 18.5 * 25kg/m2)
  • Willing to be informed about incidental findings of pathology
  • Willing to comply with the study procedures

排除标准

  • Allergy or intolerance for cow milk, lactose, soy and/or fish (self-reported)
  • Gastric disorders or regular gastric complaints, for example heart burn
  • Use of medication which alters the normal functioning of the stomach, such as:
  • Medical drug use that influences the GI tract's normal function (e.g. motility,
  • pH, etc.) or the GI tract's microbiota (e.g. antibiotics).
  • Smoking (>2 cigarettes a week)
  • Drinking more than 14 glasses of alcohol a week
  • Having given a blood donation in the past two months
  • Hb value below 8.4 mmol/L (as measured with finger-prick method)
  • Having contra-indication to MRI scanning (e.g. having a pacemaker,
  • defibrillator, intraorbital or intraocular metallic fragments, ferromagnetic
  • implants, or being claustrofobic)
  • Participating in other research during the study period
  • Not having a general practitioner or unwillingness to share unexpected findings
  • with the general practitioner
  • Being an employee or student of the division of human nutrition and health

研究者

相似试验